ctrl K

Price Alert

Pacific Biosciences of Ca... (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.23

-0.05 (-3.91%)

At close: Aug 14, 2025, 3:59 PM

1.25

1.63%

Pre-market: Aug 15, 2025, 07:34 AM EDT

Pacific Biosciences of California Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	154.01M	200.52M	128.3M	130.51M
Cost of Revenue	116.73M	147.74M	79.27M	71.65M
Gross Profit	37.28M	52.78M	49.03M	58.86M
Operating Income	-474.31M	-334.47M	-307.2M	-210.44M
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-309.54M	-318.16M	-314.25M	-274.87M
Net Income	-309.85M	-306.74M	-314.25M	-181.22M
Selling & General & Admin	175.02M	169.82M	160.85M	124.12M
Research & Development	134.92M	187.17M	193M	112.9M
Other Expenses	201.66M	30.26M	2.38M	32.27M
Operating Expenses	511.6M	387.25M	356.23M	269.3M
Interest Expense	13.41M	14.34M	14.69M	12.53M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	628.33M	534.99M	435.5M	340.95M
Income Tax Expense	316K	-11.42M	n/a	-93.65M
Shares Outstanding (Basic)	274.49M	253.63M	224.55M	203.62M
Shares Outstanding (Diluted)	288.37M	253.63M	224.55M	204.14M
EPS (Basic)	-1.13	-1.21	-1.4	-0.89
EPS (Diluted)	-1.07	-1.21	-1.4	-0.89
EBITDA	-242.78M	-271.13M	-282.24M	-250.76M
EBIT	-296.12M	-303.82M	-299.56M	-262.34M
Depreciation & Amortization	53.35M	32.69M	17.32M	11.59M